Amorce

Treatments for adults, compared

Ostinelli et al. 2025 · The Lancet Psychiatry

Question
For adults, how do medications, psychological therapies and brain stimulation compare?
Study design
Systematic review and component network meta-analysis of randomised trials in adults.
Participants
Adults with ADHD across a large set of randomised trials.
What researchers found
Only stimulants and atomoxetine consistently reduced core symptoms on both self- and clinician-rated scales in the short term. Psychological and other non-drug interventions had inconsistent effects. Evidence on quality of life and long-term outcomes was limited.
What this DOES mean
For adults, the strongest current evidence for reducing core symptoms is for medication, in the short term.
What this DOESN’T mean
It doesn’t mean therapy is useless. Many therapy trials are small and very different from each other, which makes clear effects hard to detect. Nor does it mean medication improves quality of life.
Limitations
Mixing very different therapies makes comparisons hard; few long-term trials exist.
Evidence level
Original source
  1. Meta-analysis Ostinelli EG, et al. (senior author: Cortese S) (2025). Comparative efficacy and acceptability of pharmacological, psychological, and neurostimulatory interventions for ADHD in adults: a systematic review and component network meta-analysis. The Lancet Psychiatry. Open source ↗Adults only. Short-term symptom benefits for stimulants and atomoxetine; little evidence on quality of life or long-term outcomes.